Novo Nordisk's cagrilintide shows promise in Phase 3 trial | Alan Nafiev posted on the topic US$ 20.52 Min. order: 1 piece ★★★★★ 4.5 (139 reviews) Sold : Login>>
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.6 (200 reviews) Sold : Login>>
Has anyone tried BCP-157 injections for MS? US$ 27.25 Min. order: 1 piece ★★★★★ 4.0 (186 reviews) Sold : Login>>
Novo Nordisk presents new Phase III data for next-gen amylin cagrilintide US$ 24.64 Min. order: 1 piece ★★★★★ 4.5 (156 reviews) Sold : Login>>
Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide US$ 22.60 Min. order: 1 piece ★★★★★ 4.4 (58 reviews) Sold : Login>>